IlluminOss Medical Caps off Flagship Year with Addition of New Patents to Bone Fixation Portfolio
2014 Marked by Continued Success in International Orthopedics Markets and Conditional Clearance for First U.S. Clinical Trial to Begin in 2015
East Providence, RI (December 10, 2014) – IlluminOss Medical, a commercial stage medical device company focused on minimally invasive orthopedic fracture repair, today announced that it has been issued two new patents related to its internal bone fixation system. IlluminOss now owns 25 issued U.S. patents and its complete intellectual property portfolio includes over 55 issued patents in 17 countries around the world - with many more patent applications Hollister Outlet currently pending related to its revolutionary IlluminOss System for minimally invasive fixation and treatment of broken bones.
© 2022 Pappas Capital, LLC. ALL RIGHTS RESERVED.